Press Releases
SAN CARLOS, Calif. and DALLAS, July 23, 2019 /PRNewswire/ -- LakePharma, Inc., the leading US-based biologics CRDMO, announced today that it has opened a new office in Dallas, Texas.
Read more...23 July 2019
JERSEY CITY, N.J., July 23, 2019 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the company will present an update on its REFINE-ALS biomarker study during the Centers for Disease Control and Prevention (CDC) 2019 National ALS Registry Annual Meeting in Atlanta on July 23-24.
Read more...Buck's report recommends prudent plan design to help companies control cost escalation by encouraging healthy lifestyles and embracing technology TORONTO and NEW YORK, July 23, 2019 /PRNewswire/ --
Read more...23 July 2019
CAMBRIDGE, Mass., July 23, 2019 /PRNewswire/ -- Raleigh Neurology Associates (RNA), one of the largest private neurology practices in the U.S, has joined the TriNetX global health research network adding a significant new clinical data set to the world's largest research network.
Read more...BOSTON, July 23, 2019 /PRNewswire/ -- Samus Therapeutics, Inc. ("Samus" or the "Company") today announced the initiation of its clinical program for PU-AD, an oral, brain permeable inhibitor of epichaperomes in Alzheimer's Disease (AD) following clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). Samu
Read more...MIAMI, July 23, 2019 /PRNewswire/ -- The U.S. Cannabis Conference & Expo (USCC) will be hosting for the second year at Miami's
Read more...NETANYA, Israel, July 23, 2019 /PRNewswire/ -- Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today the publication of a peer-reviewed paper demonstrating that Remote Electrical Neuromodulation (REN) is as effective as
Read more...23 July 2019
EL SEGUNDO, Calif., July 23, 2019 /PRNewswire/ -- 360-degree wellness brand Liquid I.V., renowned for its non-GMO drink mixes utilizing the breakthrough science of Cellular Transport Technology (CTT
Read more...23 July 2019
JUPITER, Fla., July 23, 2019 /PRNewswire/ -- X-Vax Technology, Inc. (X-VAX ™), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced that it has raised $56 million in an upsized Series A financing with participation from strategic and institutional
Read more...23 July 2019
LOS ANGELES, July 23, 2019 /PRNewswire/ -- The St. Baldrick's Foundation, the largest private funder of
Read more...